hsct

Conclusion HC in children after HSCT has its own clinical characteristics .

结论小儿HSCT后HC有其自身的临床特征；

Preparation and clinical application of TBI in pretreatment of HSCT

全身照射的前期准备及在造血干细胞移植预处理中的应用

Conclusions HSCT for refractory hematological diseases is safe and effective .

结论HSCT能治愈常规方法难以治疗的血液病；

27 days after HSCT , chromosome analysis of bone marrow cells showed 99 % donor type .

27d时，骨髓细胞染色体分析显示99%为供者型。

Current Approaches to Diagnosis and Treatment of Invasive Fungal Infection in HSCT Recipients & Review

造血干细胞移植后侵袭性真菌感染的诊断和治疗进展

The treatment of first choice is matched related donor ( MRD ) HSCT .

目前国际上推荐首选HLA匹配相关供者（MRD）的HSCT。

In self-care instruction , pay special attention to personal hygiene since HSCT destroyed the immune system .

自身护理的指导：HSCT破坏了人体免疫机制，需要特别注意个人卫生；

Objective : To study the secondary T cell lymphoma after hematopoietic stem cell transplantation ( HSCT ) .

目的：研究干细胞移植后T细胞淋巴瘤及发病机制。

Invasive mould infection is a major cause of morbidity and mortality in HSCT recipients .

侵袭性霉菌感染是HSCT受者发病和死亡的主要原因。

Conclusion ABO - incompatibility has no adverse effect on the outcome of HSCT .

结论ABO血型不合不影响造血干细胞移植的植活、相关合并症及预后。

HSCT is the best choice for patients with high risks , especially with additional chromsome abnormalities .

对于有高危险因素的患者，尤其是有附加染色体异常的患者，还是建议进行HSCT。

Result : 30 patients got engraftment , 2 unrelated HSCT patients suffered from secondary graft failure .

结果：30例均获得植入，2例无关供者移植出现继发性植入失败。

Conclusion FISH is likely an important tool for monitoring treatment and revealing minimal residual disease in CML after HSCT .

结论FISH可能成为白血病造血干细胞移植后疗效观察和微小残留病定量监测的重要手段。

In this review , the early diagnosis and treatment of IFI in HSCT recipients are summarized .

本文主要综述了HSCT受者出现IFI的早期诊疗方法。

Donors and recipients infected with hepatitis B are not contraindication of HSCT ;

供、受者感染乙肝病毒不是HSCT的绝对禁忌证；

Objective To study the clinical features and the incidence of early infectious complications following children hematopoietic stem cells transplantation ( HSCT ) .

目的了解儿童脐血及外周血造血干细胞移植早期感染发生的情况及其影响因素。

Conclusion : Cytogenetic examination after hematopoietic stem cell transplantation in leukemia may be useful for observing short term effect of HSCT .

结论：造血干细胞移植后白血病细胞遗传学检测可观察近期疗效，指导后续治疗选择。

Conclusion Sensitized donor lymphocytes infusion after HSCT evidently promoted the immune reconstitution and reduced the incidence of GVHD .

结论造血干细胞移植后输注致敏供者的淋巴细胞能促进受者的免疫功能重建，并可减少GVHD的发生。

HSCT should be recommended to t ( 8 ; 21 ) AML in China , especially to those with adverse prognostic factors .

对于具有不良预后因素的t（8；21）AML患者应该建议接受造血干细胞移植。

High-dose chemotherapy supported by hematopoietic stem / progenitor cells transplantation ( HSCT ) presents an effective access of final cure of leukemia .

白血病是严重危害人民健康的常见血液系统恶性肿瘤，高剂量化疗联合造血干/祖细胞移植已成为最终治愈白血病的有效途径。

Objectives To determine current use of HSCT to assess differences in its application and to explore associations of macroeconomic factors with transplant rates on a global level .

目的明确目前造血干细胞移植的开展情况，以评估其差异，并在全球水平上探讨与移植率相关的宏观经济因素。

Relationship between the Genetic Background of Donor KIR-recipient HLA and the Outcomes in HLA-identical Sibling HSCT

供者KIR和受者HLA遗传背景与亲缘全相合HSCT预后的关系

Twelve ( 8 males and 4 females ) patients with β - thalassemia major received the hematological stem cell transplantation ( HSCT ) .

12例接受造血干细胞移植治疗的重型β地中海贫血患儿，年龄从25岁～115岁，男8例，女4例。

This represents a major advance for antifungal therapy in haematological malignancy patients undergoing chemotherapy or haematopoietic stem cell transplant ( HSCT ) .

这是接受化疗或造血干细胞移植（HSCT）血液恶性肿瘤患者抗真菌治疗的重大进展。

Objective To detect bcr gene rearrangement in chronic myeloid leukemia ( CML ) after hematopoietic stem cell transplantation ( HSCT ) in quantity .

目的定量检测慢性髓细胞白血病（CML）造血干细胞移植（HSCT）后bcr基因重排。

The thesis combines theory with practice and uses strategy management to research the HSCT company in order to transform strategy into action and make the research more targeted , practicable and operational .

本文理论联系实际，以HSCT公司为研究对象进行战略发展研究，旨在将HSCT公司的战略转化为行动计划，力求研究的针对性、实用性和可操作性。

It is concluded that the minor histocompatibility antigen HA-1 can be considered as a target of immunotherapy against leukemia after HSCT .

结论次要组织相容性抗原HA-1可作为造血干细胞移植后抗白血病治疗的靶点。

During the process of HLA-unmatched donor HSCT , completely elimination of mature T lymphocyte followed by CsA administration can also prevent most of GVHD .

在HLA配型不相合移植中，如果清除了成熟T细胞，在CsA等药物作用下同样能阻止多数GVHD的发生。

The frequency of graft-versus-host disease ( GVHD ), which is a severe side effect of HSCT in patients , is reduced among patients receiving transplants from UCB .

同时研究发现接受脐带血移植的病人的移植物抗宿主病（GVHD）的频率明显减小。

In 30 patients with pneumonia after HSCT , 8 were positive in sputum antigens for a rate of 26 . 67 % ( 8 / 30 ) .

30例肺炎患者痰液抗原阳性8例，阳性率为26.67%，8例抗原阳性患者中只有3例发现包囊，符合率为37.5%。